Resistance of Young Mice to Pneumococcal Infection can be Improved by Oral Vaccination with Recombinant Lactococcus lactis

Journal of Microbiology, Immunology and Infection

Volumn 43, Issue 1, 2010, Pages 1-10

  Villena, Julio ^a,b   Medina, Marcela ^a   Racedo, Silvia ^a   Alvarez, Susana ^a,b  

^a CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

^b UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

Author keywords

Lactococcus lactis; oral vaccine; recombinant PppA; Streptococcus pneumoniae; young mice

Indexed keywords

BACTERIAL VACCINE; BACTERIUM ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PROTEIN A; RECOMBINANT LACTOCOCCUS LACTIS PNEUMOCOCCAL PROTECTIVE PROTEIN A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY AFFINITY; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BACTEREMIA; BACTERIAL COUNT; BACTERIAL IMMUNITY; BACTERIAL STRAIN; BLOOD CULTURE; CELL COUNT; CONTROLLED STUDY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE TEST; INFECTION PREVENTION; INTESTINE FLUID; LACTOCOCCUS LACTIS; LUNG LAVAGE; MALE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; OPSONIZATION; OPTIMAL DRUG DOSE; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PNEUMOCOCCAL INFECTION; RESPIRATORY TRACT INFECTION; SEROTYPE; SINGLE DRUG DOSE; STREPTOCOCCUS PNEUMONIAE; TH1 CELL; TH2 CELL; VACCINATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTEREMIA; COLONY COUNT, MICROBIAL; GASTROINTESTINAL TRACT; GENETIC VECTORS; IMMUNITY, MUCOSAL; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; LACTOCOCCUS LACTIS; LUNG; MALE; MICE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RESPIRATORY SYSTEM; STREPTOCOCCUS PNEUMONIAE; TH1 CELLS; TH2 CELLS; VACCINATION;

EID: 77949564520     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1684-1182(10)60001-1     Document Type: Article

References (26)

1. Bogaert D., Groot R., and Hermans P.W.M. Streptococcus pneumoniae colonization: the key to pneumococcal disease. Lancet Infect Dis 4 (2004) 144-154
2. World Health Organization. Pneumococcal vaccines (position paper). Wkly Epidemiol Rec 74 (1999) 177-183
3. Hausdorff W.P., Bryant J., Paradiso P.R., and Siber G.R. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use. Clin Infect Dis 30 (2000) 100-121
4. Jackson C.R. Clinical experience with pneumococcal conjugate vaccines in infants and children. JAOA 102 (2002) 431-436
5. Alvarez S., Herrero C., Bru E., and Perdigón G. Effect of Lactobacillus casei and yogurt administration on prevention of Pseudomonas aeruginosa infection in young mice. J Food Protect 64 (2001) 1768-1774
6. Alvarez S, Villena J, Racedo S, Salva S, Agüero G. Malnutrition, probiotics and respiratory infections. In: Research Advances in Nutrition. Edited by Global Research Network: Kerala, India 2007:9-23.
7. Cross M.L. Microbes versus microbes: immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens. FEMS Immunol Med Microbiol 34 (2002) 245-253
8. Perdigón G., Alvarez S., Medina M., Vintiñi E., and Roux E. Influence of the oral administration of lactic acid bacteria on IgA producing cells associated to bronchus. Int J Immunopathol Pharmacol 12 (1999) 97-102
9. Villena J., Racedo S., Agüero G., and Alvarez S. Yogurt accelerates the recovery of defence mechanisms against Streptococcus pneumoniae in protein malnourished mice. Brit J Nutr 95 (2006) 591-602
10. Le Loir Y., Azevedo V., Oliveira S.C., Freitas D.A., Miyoshi A., Bermudez-Humaran L.G., et al. Protein secretion in Lactococcus lactis: an efficient way to increase the overall heterologous protein production. Microbial Cell Fact 4 (2005) 1-12
11. Villena J., Medina M., Vintiñi E., and Alvarez S. Stimulation of respiratory immunity by oral administration of Lactococcus lactis. Can J Microbiol 54 (2008) 630-638
12. Medina M., Villena J., Vintiñi E., Hebert E.M., Raya R., and Alvarez S. Nasal immunization with Lactococcus lactis expressing the pneumococcal protective protein A induces protective immunity in mice. Infect Immun 76 (2008) 2696-2705
13. Villena J., Medina M., Raya R., and Alvarez S. Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection. Can J Microbiol 54 (2008) 845-853
14. Siegrist C.A. Neonatal and early life vaccinology. Vaccine 19 (2001) 3331-3346
15. Siegrist C.A. The challenges of vaccine responses in early life: selected examples. J Comp Path 137 (2007) S4-S9
16. Racedo S., Villena J., Medina M., Agüero G., Rodríguez V., and Alvarez S. Lactobacillus casei administration reduces lung injuries in a Streptococcus pneumoniae infection. Microb Infect 8 (2006) 2359-2366
17. Green B.A., Zhang Y., Masi A.W., Barniak V., Wetherell M., Smith R.P., et al. PppA, a surface-exposed protein of Streptococcus pneumoniae, elicits cross-reactive antibodies that reduce colonization in a murine intranasal immunization and challenge model. Infec Immun 73 (2005) 981-989
18. Anttila M., Eskola J., Åhman H., and Käyhty H. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines. J Infect Dis 177 (1998) 1614-1621
19. Villena J., Racedo S., Agüero G., Bru E., Medina M., and Alvarez S. Lactobacillus casei improves resistance to pneumococcal respiratory infection in malnourished mice. J Nutr 135 (2005) 1462-1469
20. Mollerach M., Regueira M., Bonofiglio L., Callejo R., Pace J., Di Fabio J.L., Hollingshead S., and Briles D. the Streptococcus pneumoniae Working Group Invasive Streptococcus pneumoniae isolates from Argentinian children: serotypes, families of pneumococcal surface protein A (PspA) and genetic diversity. Epidemiol Infect 132 (2004) 177-184
21. Hausdorff W.P., Feikin D.R., and Klugman K.P. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 5 (2005) 83-93
22. McGhee J.R., Mestecky J., Dertzbaugh M.T., Eldridge J.H., Hirasawa M., and Kiyono H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10 (1992) 75-88
23. Pastoret P.P. Challenges and issues of early life vaccination in animals and humans. J Comp Path 137 (2007) S2-S3
24. Yam K.K., Pouliot P., N'diaye M.M., Fournier S., Olivier M., and Cousineau B. Innate inflammatory responses to the Grampositive bacterium Lactococcus lactis. Vaccine 26 (2008) 2689-2699
25. Kiyono H., and Fukuyama S. NALT-versus Peyer's patch mediated mucosal immunity. Nat Rev Immunol 4 (2004) 699-710
26. Twigg H.L. Humoral immune defense (antibodies): recent advances. Proc Am Thorac Soc 2 (2005) 417-421